S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Baxter International Stock Price, News & Analysis (NYSE:BAX)

$87.02
-0.72 (-0.82 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$86.37
Now: $87.02
$88.06
50-Day Range
$83.89
MA: $87.18
$89.78
52-Week Range
$61.05
Now: $87.02
$89.93
Volume2.30 million shs
Average Volume2.66 million shs
Market Capitalization$44.43 billion
P/E Ratio28.53
Dividend Yield1.00%
Beta0.99
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.55 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$44.43 billion
Next Earnings Date10/24/2019 (Confirmed)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, July 16th. Stockholders of record on Friday, August 30th will be given a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, August 29th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International declared that its Board of Directors has initiated a share repurchase program on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.1% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's leadership believes its stock is undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) issued its earnings results on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.81 by $0.08. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The company's revenue was down .1% on a year-over-year basis. During the same quarter last year, the business posted $0.77 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Baxter International.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $3.34-3.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.33. The company issued revenue guidance of $11.24-11.35 billion, compared to the consensus revenue estimate of $11.23 billion.

What price target have analysts set for BAX?

15 brokers have issued 1 year target prices for Baxter International's shares. Their predictions range from $70.00 to $95.00. On average, they expect Baxter International's share price to reach $85.64 in the next twelve months. This suggests that the stock has a possible downside of 1.6%. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

News headlines about BAX stock have trended positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Baxter International.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 6,470,000 shares, an increase of 32.6% from the August 30th total of 4,880,000 shares. Based on an average daily trading volume, of 2,380,000 shares, the short-interest ratio is presently 2.7 days. Currently, 1.3% of the shares of the stock are sold short. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Honeywell International (HON), Johnson & Johnson (JNJ), Micron Technology (MU), Cisco Systems (CSCO), Pfizer (PFE) and Allergan (AGN).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Gateway Investment Advisers LLC (0.06%), Meyer Handelman Co. (0.05%), State of Alaska Department of Revenue (0.03%), Varma Mutual Pension Insurance Co (0.03%), Dalton Greiner Hartman Maher & Co. (0.02%) and Gulf International Bank UK Ltd (0.02%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Decatur Capital Management Inc., Northpointe Capital LLC, CIBC Private Wealth Group LLC, CenturyLink Investment Management Co, Exane Derivatives, Tributary Capital Management LLC and Park National Corp OH. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which institutional investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Varma Mutual Pension Insurance Co, TIAA FSB, Pacer Advisors Inc., Cerebellum GP LLC, DNB Asset Management AS and NuWave Investment Management LLC. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $87.02.

How big of a company is Baxter International?

Baxter International has a market capitalization of $44.43 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  623 (Vote Outperform)
Underperform Votes:  548 (Vote Underperform)
Total Votes:  1,171
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel